CARGO Therapeutics (NASDAQ: CRGX) reported Q3 EPS of ($47.37).

As of September 30, 2023, CARGO had cash and cash equivalents of $60.3 million and approximately $438 million, as adjusted for the net proceeds from the third tranche of the Company’s Series A financing in October and its IPO in November which it expects will fund operations through 2025.

For earnings history and earnings-related data on CARGO Therapeutics (CRGX) click here.